ENTRY       D10766                      Drug
NAME        Osimertinib mesylate (USAN);
            Osimertinib mesilate (JAN);
            Tagrisso (TN)
PRODUCT     TAGRISSO (AstraZeneca Pharmaceuticals LP)
FORMULA     C28H33N7O2. CH4SO3
EXACT_MASS  595.2577
MOL_WEIGHT  595.713
CLASS       Antineoplastic
             DG01918  Tyrosine kinase inhibitor
              DG01917  Receptor tyrosine kinase inhibitor
               DG03162  EGFR inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Transporter inhibitor
             DG02862  ABCG2 inhibitor
REMARK      Therapeutic category: 4291
            ATC code: L01EB04
            Product: D10766<JP/US>
EFFICACY    Antineoplastic, Receptor tyrosine kinase inhibitor
  DISEASE   Non-small cell lung cancer (EGFR mutation positive) [DS:H00014]
TARGET      EGFR* [HSA_VAR:1956v2] [HSA:1956] [KO:K04361]
  PATHWAY   hsa01521(1956)  EGFR tyrosine kinase inhibitor resistance
            hsa04010(1956)  MAPK signaling pathway
            hsa04012(1956)  ErbB signaling pathway
            hsa05200(1956)  Pathways in cancer
            hsa05223(1956)  Non-small cell lung cancer
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION Transporter inhibition: ABCG2 [HSA:9429]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
                 L01EB04 Osimertinib
                  D10766  Osimertinib mesylate (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Osimertinib
                D10766  Osimertinib mesylate (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D10766  Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01918  Tyrosine kinase inhibitor
               DG01917  Receptor tyrosine kinase inhibitor
                DG03162  EGFR inhibitor
                 D10766  Osimertinib mesylate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D10766  Osimertinib mesylate
             Transporter inhibitor
              DG02862  ABCG2 inhibitor
               D10766  Osimertinib mesylate
            Drug classes [BR:br08332]
             Antineoplastic
              DG03162  EGFR inhibitor
               D10766  Osimertinib mesylate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR* [HSA_VAR:1956v2]
                 D10766  Osimertinib mesylate (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10766
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10766
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10766
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10766
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10766
             Drug transporters
              D10766
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D10766
DBLINKS     CAS: 1421373-66-1
            PubChem: 310920484
            ChEBI: 90948
ATOM        42
            1   C8y C    15.8155  -13.2242
            2   N5x N    15.8155  -14.6236
            3   C8y C    17.0050  -15.3233
            4   N5x N    18.2645  -14.6236
            5   C8x C    18.2645  -13.2242
            6   C8x C    17.0050  -12.5245
            7   C8y C    14.6003  -12.5262
            8   C8x C    14.6279  -11.1251
            9   N4y N    13.3039  -10.6659
            10  C8y C    12.4581  -11.7832
            11  C8y C    13.2592  -12.9328
            12  C8x C    11.0637  -11.9021
            13  C8x C    10.4694  -13.1690
            14  C8x C    11.2707  -14.3187
            15  C8x C    12.6650  -14.1998
            16  C1a C    12.8886   -9.2966
            17  N1b N    16.9878  -16.7226
            18  C8y C    18.2037  -17.4448
            19  C8x C    18.1866  -18.8219
            20  C8y C    19.3897  -19.5366
            21  C8y C    20.6803  -18.8521
            22  C8x C    20.6274  -17.4750
            23  C8y C    19.4243  -16.7602
            24  O2a O    19.3720  -15.3934
            25  C1a C    20.6720  -14.7043
            26  N1b N    19.3724  -20.9210
            27  C5a C    18.1606  -21.6005
            28  C2b C    16.9914  -20.9059
            29  O5a O    18.1425  -23.0191
            30  C2a C    15.7749  -21.5882
            31  N1c N    21.8239  -19.5735
            32  C1b C    23.0438  -18.8898
            33  C1a C    21.8058  -20.9907
            34  C1b C    24.2317  -19.5961
            35  N1c N    25.4394  -18.9193
            36  C1a C    26.6533  -19.6413
            37  C1a C    25.3871  -17.4925
            38  S4a S    25.1915  -11.9653
            39  O1d O    25.1915  -10.5658
            40  O1d O    25.1915  -13.3647
            41  C1a C    23.7921  -11.9653
            42  O1d O    26.5909  -11.9653
BOND        44
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12    7  11 1
            13   10  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17   11  15 2
            18    9  16 1
            19    3  17 1
            20   17  18 1
            21   18  19 2
            22   19  20 1
            23   20  21 2
            24   21  22 1
            25   22  23 2
            26   18  23 1
            27   23  24 1
            28   24  25 1
            29   20  26 1
            30   26  27 1
            31   27  28 1
            32   27  29 2
            33   28  30 2
            34   21  31 1
            35   31  32 1
            36   31  33 1
            37   32  34 1
            38   34  35 1
            39   35  36 1
            40   35  37 1
            41   38  39 2
            42   38  40 2
            43   38  41 1
            44   38  42 1
///
